Eversept Partners as of Dec. 31, 2020
Portfolio Holdings for Eversept Partners
Eversept Partners holds 60 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corp Spons Adr New (AMRN) | 9.3 | $78M | 16M | 4.89 | |
| United Therapeutics Corporation (UTHR) | 8.3 | $70M | 459k | 151.79 | |
| Alexion Pharmaceuticals | 7.0 | $59M | 376k | 156.24 | |
| Tg Therapeutics (TGTX) | 5.3 | $45M | 864k | 52.02 | |
| Astrazeneca Sponsored Adr (AZN) | 5.1 | $43M | 852k | 49.99 | |
| Horizon Therapeutics Pub L SHS | 4.6 | $39M | 531k | 73.15 | |
| Fate Therapeutics (FATE) | 4.3 | $36M | 400k | 90.93 | |
| Glaxosmithkline Sponsored Adr | 4.2 | $35M | 947k | 37.18 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.7 | $31M | 187k | 166.78 | |
| Catalent (CTLT) | 3.5 | $29M | 280k | 104.07 | |
| Envista Hldgs Corp (NVST) | 3.5 | $29M | 861k | 33.73 | |
| Danaher Corporation (DHR) | 3.3 | $28M | 126k | 222.29 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.2 | $27M | 2.7M | 9.65 | |
| Avantor (AVTR) | 3.1 | $26M | 921k | 28.15 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $24M | 139k | 170.49 | |
| Anthem (ELV) | 2.5 | $21M | 66k | 321.08 | |
| Zogenix Com New | 2.2 | $18M | 910k | 19.99 | |
| Qiagen Nv Shs New | 2.1 | $18M | 337k | 52.85 | |
| Ensign (ENSG) | 1.8 | $15M | 209k | 72.98 | |
| Deciphera Pharmaceuticals (DCPH) | 1.7 | $14M | 246k | 57.07 | |
| Intra Cellular Therapies (ITCI) | 1.3 | $11M | 356k | 31.80 | |
| Taro Pharmaceutical Inds SHS (TARO) | 1.3 | $11M | 152k | 73.42 | |
| Heska Corp Com Restrc New | 1.3 | $11M | 76k | 145.66 | |
| Kadmon Hldgs | 1.2 | $10M | 2.4M | 4.15 | |
| Biohaven Pharmaceutical Holding | 1.1 | $8.9M | 104k | 85.71 | |
| Magellan Health Com New | 1.0 | $8.7M | 105k | 82.84 | |
| Rite Aid Corporation (RADCQ) | 1.0 | $8.4M | 532k | 15.83 | |
| Aurinia Pharmaceuticals (AUPH) | 1.0 | $8.4M | 604k | 13.83 | |
| Seres Therapeutics (MCRB) | 1.0 | $8.2M | 334k | 24.50 | |
| Glaxosmithkline Call | 0.9 | $7.4M | 3.5k | 2089.90 | |
| Quidel Corporation | 0.9 | $7.3M | 41k | 179.66 | |
| Affimed Therapeutics B V | 0.7 | $5.6M | 965k | 5.82 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.6 | $5.4M | 1.2M | 4.57 | |
| Oxford Immunotec Global Ord Shs | 0.6 | $5.4M | 308k | 17.47 | |
| Altimmune Com New (ALT) | 0.5 | $4.3M | 380k | 11.28 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $3.7M | 492k | 7.45 | |
| Five Prime Therapeutics | 0.4 | $3.6M | 209k | 17.01 | |
| Sanofi Sponsored Adr (SNY) | 0.4 | $3.3M | 68k | 48.59 | |
| Hca Holdings (HCA) | 0.3 | $2.8M | 17k | 164.44 | |
| Prothena Corp SHS (PRTA) | 0.3 | $2.4M | 203k | 12.01 | |
| Sesen Bio | 0.3 | $2.1M | 1.6M | 1.35 | |
| Anaptysbio Inc Common (ANAB) | 0.2 | $1.9M | 88k | 21.50 | |
| SurModics (SRDX) | 0.2 | $1.8M | 41k | 43.51 | |
| Oncternal Therapeutics | 0.2 | $1.7M | 344k | 4.90 | |
| Otonomy | 0.2 | $1.6M | 253k | 6.47 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $1.4M | 155k | 8.94 | |
| Concert Pharmaceuticals I equity | 0.2 | $1.3M | 104k | 12.64 | |
| Catabasis Pharmaceuticals In Com New | 0.1 | $1.1M | 522k | 2.14 | |
| Exagen (XGN) | 0.1 | $1.1M | 82k | 13.20 | |
| Dex (DXCM) | 0.1 | $914k | 2.5k | 369.59 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $879k | 36k | 24.21 | |
| Iqvia Holdings (IQV) | 0.1 | $732k | 4.1k | 179.19 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $590k | 5.0k | 118.55 | |
| Amarin Corp Call | 0.1 | $471k | 13k | 36.64 | |
| Gohealth Com Cl A | 0.0 | $405k | 30k | 13.64 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $359k | 19k | 18.97 | |
| Zymeworks | 0.0 | $255k | 5.4k | 47.18 | |
| Merus N V (MRUS) | 0.0 | $253k | 14k | 17.51 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $218k | 3.8k | 57.13 | |
| Community Health Systems (CYH) | 0.0 | $95k | 13k | 7.42 |
